First in human measurements of abscess cavity optical properties and methylene blue uptake prior to photodynamic therapy by in vivo diffuse reflectance spectroscopy

Efficacious photodynamic therapy (PDT) of abscess cavities requires personalized treatment planning. This relies on knowledge of abscess wall optical properties, which we report for the first time in human subjects. The objective was to extract optical properties and photosensitizer concentration fr...

Full description

Saved in:
Bibliographic Details
Published inJournal of biomedical optics Vol. 29; no. 2; p. 027002
Main Authors Hannan, Md Nafiz, Sharma, Ashwani K., Baran, Timothy M.
Format Journal Article
LanguageEnglish
Published United States Society of Photo-Optical Instrumentation Engineers 01.02.2024
SPIE
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Efficacious photodynamic therapy (PDT) of abscess cavities requires personalized treatment planning. This relies on knowledge of abscess wall optical properties, which we report for the first time in human subjects. The objective was to extract optical properties and photosensitizer concentration from spatially resolved diffuse reflectance measurements of abscess cavities prior to methylene blue (MB) PDT, as part of a phase 1 clinical trial. Diffuse reflectance spectra were collected at the abscess wall of 13 human subjects using a custom fiber-optic probe and optical spectroscopy system, before and after MB administration. A Monte Carlo lookup table was used to extract optical properties. Pre-MB abscess wall absorption coefficients at 665 nm were (0.03 to ) and (0.08 to ) post-MB. Reduced scattering coefficients at 665 nm were (4.8 to ) and (1.6 to ) for pre-MB and post-MB, respectively. Oxygen saturations were found to be (5.6% to 100%) pre-MB and (0.0001% to 76.4%) post-MB. Determined MB concentrations were (0 to ). We observed substantial inter-subject variation in both native wall optical properties and MB uptake. This underscores the importance of making these measurements for patient-specific treatment planning.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1083-3668
1560-2281
1560-2281
DOI:10.1117/1.JBO.29.2.027002